Initial findings following the routine implementation of electronic patient reported outcome measures (ePROMs) for patients with lung cancer at the Christie NHS Foundation Trust
Crockett, Cathryn Chan, Clara Coote, Joanna H Harris, Maggie A Pemberton, Laura S Salem, Ahmed Sheikh, Hamid Y Woolf, David K Yorke, Janelle
Crockett, Cathryn
Chan, Clara
Coote, Joanna H
Harris, Maggie A
Pemberton, Laura S
Salem, Ahmed
Sheikh, Hamid Y
Woolf, David K
Yorke, Janelle
Citations
Altmetric:
Abstract
Introduction: The Christie NHS Foundation Trust introduced
ePROMs routinely for all patients with lung cancer in January 2019.
Patients remotely complete a questionnaire assessing symptoms
and quality of life (QoL) using an online platform ‘My Christie-My
Health’. The results are used to offer patients symptom advice, if
applicable, and help clinicians to better guide consultations.
Methods: The demographic information and ePROM responses for
lung cancer patients who completed the questionnaires between
January 2019 and December 2020 at the Christie were extracted
from electronic medical records. The resulting database was then
manually cleaned. Differences in reported symptoms and QoL
measures pre and post palliative systemic anticancer therapy (SACT)
and radical thoracic radiotherapy were compared using Wilcoxon
signed rank tests on the statistical software JASP 0.13.1.
Questionnaires were considered pre-treatment if they were
completed up to a maximum of one month before treatment started.
Post-treatment questionnaires differed according to the treatment
type i.e., for SACT = from day one up to three weeks after completion
and for radiotherapy = halfway through the treatment course up to
six weeks after completion.
Results: Figure 1 displays the details of our findings. Palliative
lung SACT was associated with a significant improvement in cough (p=<0.001) and coughing up blood (p=0.025), but significantly
impacted mobility (p=0.013). Patients receiving radical thoracic
radiotherapy also reported a significant improvement in coughing
up blood (p=0.042) but worse pain (p=0.002) and tiredness (p=0.01).
Other changes in symptoms and QoL after SACT or radiotherapy
were not significant.
Conclusion: The ePROM questionnaire used routinely at the Christie
NHS Foundation Trust in patients with lung cancer demonstrates
adequate validity, as these changes in symptoms and QoL are in
keeping with those expected following palliative SACT and radical
thoracic radiotherapy.
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Crockett C, Bayman N, Chan C, Coote J, Harris M, Pemberton L, et al. Initial findings following the routine implementation of electronic patient reported outcome measures (ePROMs) for patients with lung cancer at the Christie NHS Foundation Trust. Vol. 165, Lung Cancer. Elsevier BV; 2022. p. S8.